These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10440558)

  • 1. Causal inference in a clinical trial: a comparative example.
    Heitjan DF
    Control Clin Trials; 1999 Aug; 20(4):309-18. PubMed ID: 10440558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.
    Ravnborg M; Bendtzen K; Christensen O; Jensen PE; Hesse D; Tovey MG; Sørensen PS
    Mult Scler; 2009 Mar; 15(3):323-8. PubMed ID: 19028832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reaction to azathioprine.
    Fields CL; Robinson JW; Roy TM; Ossorio MA; Byrd RP
    South Med J; 1998 May; 91(5):471-4. PubMed ID: 9598858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis.
    Pulicken M; Bash CN; Costello K; Said A; Cuffari C; Wilterdink JL; Rogg JM; Mills P; Calabresi PA
    Mult Scler; 2005 Apr; 11(2):169-74. PubMed ID: 15794390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].
    Störh M
    Nervenarzt; 2002 Dec; 73(12):1207; author reply 1207. PubMed ID: 12599336
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrathecal immunoglobulin synthesis in multiple sclerosis: effect of corticosteroids and azathioprine.
    Miró J; Aguayo F; Garrido JC; Alvarez C; Polo JM; Pascual J; Berciano J
    Eur Neurol; 1992; 32(6):349-53. PubMed ID: 1337041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis.
    Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Syndulko K; Holevoet-Howson MI; Lerner CD; Frane MV; Pettler-Jennings P
    Neurology; 1989 Aug; 39(8):1018-26. PubMed ID: 2668784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topic.
    Zarkou S; Carter JL; Wellik KE; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2010 May; 16(3):212-4. PubMed ID: 20445436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
    Sticherling M; Franke A; Aberer E; Gläser R; Hertl M; Pfeiffer C; Rzany B; Schneider S; Shimanovich I; Werfel T; Wilczek A; Zillikens D; Schmidt E
    Br J Dermatol; 2017 Nov; 177(5):1299-1305. PubMed ID: 28494097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D
    J Neurol Sci; 2004 Aug; 223(1):73-9. PubMed ID: 15261565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic potential of interferon beta-1b and related drugs in multiple sclerosis: comparative meta-analysis].
    Cendrowski W
    Neurol Neurochir Pol; 2001; 35(4 Suppl):125-38. PubMed ID: 11873611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autoimmune hepatitis].
    Manns MP; Strassburg CP
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():39-42. PubMed ID: 12467006
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.
    Confavreux C; Saddier P; Grimaud J; Moreau T; Adeleine P; Aimard G
    Neurology; 1996 Jun; 46(6):1607-12. PubMed ID: 8649558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis.
    Mertin J; Knight SC; Rudge P; Thompson EJ; Healy MJ
    Lancet; 1980 Nov; 2(8201):949-51. PubMed ID: 6107592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa; Kir'iakov VA; Sapfirova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):119-26. PubMed ID: 2160156
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
    Illei GG; Austin HA; Crane M; Collins L; Gourley MF; Yarboro CH; Vaughan EM; Kuroiwa T; Danning CL; Steinberg AD; Klippel JH; Balow JE; Boumpas DT
    Ann Intern Med; 2001 Aug; 135(4):248-57. PubMed ID: 11511139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive therapy in multiple sclerosis].
    Vinychuk SM; Mialovyts'ka OA; Koliendo OO
    Lik Sprava; 2003; (7):76-81. PubMed ID: 14723143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone in multiple sclerosis: a comparative dose study.
    Bindoff L; Lyons PR; Newman PK; Saunders M
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1108-9. PubMed ID: 3063777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.